The QualityStocks Daily Monday, April 9th, 2018

Today's Top 3 Investment Newsletters

MarketBeat (AVXS) +81.57%

QualityStocks (SKVI) +50.00%

NetworkNewsWire (AVOP) +32.67%

The QualityStocks Daily Stock List

Trans World Corp. (TWOC)

Wall Street Resources, Marketbeat, Zacks, Investor-Advantage, and SmallCapVoice reported beforehand on Trans World Corp. (TWOC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Trans World Corp. is a leading owner and operator of casinos and hotels in Europe. The Company, along with its subsidiaries, acquires, develops, and manages casino operations and small-to-mid-size four-star hotels in Europe. Formed in 1993, Trans World is based in New York, New York.

The Company operates through two segments, Casino and Hotel. It owns and operates casinos and a hotel in the Czech Republic along the German and Austrian borders.

Pertaining to its Casino division, Trans World created the brand name of American Chance Casinos (ACC). Each unit offers an assortment of table games and state-of-the-art, popular slot machines.

The Company’s casinos include the Ceska Kubice Casino; Casino Route 55, and Casino Route 59. The Ceska Kubice Casino is on the Czech-German border.

The Casino Route 55, in Dolni Dvoriste, is on the Czech-Austrian border.

The Casino Route 59 is about 45 minutes north of Vienna near Znojmo.

Concerning its Hotel division, Trans World is planning the development of a number of hotels. These will be located on or near the sites of the ACC casinos. The first of these hotels, Hotel Savannah, was completed in early 2009. It is next to the Route 59 Casino.

Trans World’s second property is the renovated Hotel Columbus. It was acquired in September of 2014. It is in Seligenstadt, roughly 25 kilometers from Frankfurt, Germany.

Trans World’s third property is the Hotel Freizeit Auefeld. It was acquired in June of 2015. Hotel Freizeit Auefeld is in Hann. Münden, Germany.

On December 21, 2016, the Company acquired via its subsidiary Trans World Hotels Germany GmbH (TWHG), the Lindner Sport & Aktivhotel Kranichhöhe (Lindner Hotel). This is a business and recreational hotel property in Much, Germany, roughly 19 miles northeast of Bonn.

The Company operates the hotel under its Trans World Hotels (TWH) brand. Trans World planned renovations to upgrade the property to four-stars from its three-star rating. It renamed the property “Hotel Kranichhöhe”.

On March 1, 2017, through its subsidiaries, Trans World Hotels & Entertainment a.s. (TWH&E) and TWHG, it purchased the ground lease rights to a four-star business hotel situated on the banks of the Danube River in Linz, Austria.

Last month, Trans World announced it entered into a definitive merger agreement providing for Trans World to become an indirect wholly-owned subsidiary of Far East Consortium International Limited (FEC).

With the terms of the merger agreement, FEC Investment (US) Limited (FEC US), a direct wholly-owned subsidiary of FEC Overseas Investment (UK) Limited (FEC OIL), an indirect wholly-owned subsidiary of FEC, will purchase (and merge with and into) Trans World, which will become a wholly-owned subsidiary of FEC OIL. FEC involves in property development and investment, hotel operations and management, and car park and facilities management, in the Asia Pacific region and Europe.

Mr. Michael Brodsky, Chairman of the Board of Trans World, said, "We are pleased to announce the planned merger of Trans World with FEC, reflecting an enterprise value of approximately $53 million. Trans World will be an excellent addition to the FEC portfolio of companies, as our business models and strategy are closely aligned. The Board and I believe this is the right move for the Company at an attractive valuation for our shareholders."

Trans World Corp. (TWOC), closed Monday's trading session at $3.90, even for the day, on 11,500 volume with 12 trades. The average volume for the last 60 days is 1,654 and the stock's 52-week low/high is $2.25/$7.25.


Aequus Pharmaceuticals, Inc. (AQSZF)

StockDailyReview, PennyStockTweets, Investopedia, 4-Traders, OTC Markets, Barchart, Marketwired, InvestorsHub, Stockhouse, and MarketWatch reported on Aequus Pharmaceuticals, Inc. (AQSZF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A specialty pharmaceutical company, Aequus Pharmaceuticals, Inc.’s focus is on developing, advancing, and promoting differentiated products. The Company’s development stage pipeline includes a number of products in neurology and psychiatry with the aim of addressing the need for improved medication adherence via enhanced delivery systems. OTCQB-listed, Aequus Pharmaceuticals is headquartered in Vancouver, British Columbia.

The Company’s most recent addition to the development pipeline was a long-acting form of medical cannabis. Aequus’ intention is to commercialize its internal programs in Canada together with its present portfolio of marketed established medicines.

Aequus Pharmaceuticals will look to form strategic partnerships, which would maximize the reach of its product candidates globally. Its plan is to build on its Canadian commercial platform via the launch of more products that are either created internally or brought in via an acquisition or license.

Aequus has two preclinical programs now in formulation optimization, AQS-1302 and AQS-1303. AQS-1302 is being advanced for the potential treatment of epilepsy with a once-weekly transdermal application. This is to provide patients with steady-state delivery of their medication. The expectation is that this product will decrease their risk of experiencing breakthrough seizures.

AQS-1303 is in development for the management of Nausea and Vomiting of Pregnancy (NVP). The expectation is that it will provide consistent anti-emetic control. This is while eliminating the risk of missed doses because of emesis (vomiting).

Aequus’ partners include Supernus Pharmaceuticals, Inc., Corium International, Inc., and Transdermal Research Pharm Lab. The Company will continue to expand its commercial pipeline with high quality, differentiated products. These include patented products, branded generics, and reformulated novel-delivery products within focused therapeutic areas. Aequus is developing numerous products in neurology and psychiatry. The aim is addressing the need for improved medication adherence by way of enhanced delivery systems.

This past September, Aequus Pharmaceuticals announced positive results from an initial Proof of Concept clinical study for its long-acting transdermal anti-nausea patch, AQS1303, containing the combination of pyridoxine hydrochloride and doxylamine succinate (the active ingredients in Diclegis®/Diclectin®).

The single-dose cross-over comparative bioavailability study in comparison to the presently approved oral version, Diclegis®/Diclectin®, was successfully completed in nine healthy female volunteers. The results suggested that sustained delivery of therapeutic levels of the active ingredients via the skin over a multi-day period is possible with the present formulation. The formulation was well tolerated. No serious adverse events were reported.

Last month, Aequus Pharmaceuticals announced that the European Patent Office issued an intention to grant a European patent for AQS1301, Aequus' once-weekly transdermal patch containing aripiprazole. AQS1301 is in development for the treatment of certain psychiatric disorders.

The intention of AQS1301 is to provide patients with a long-acting dosing alternative, which is comfortable, convenient, and user-friendly in an effort to promote medication adherence.  This is the eighth regional patent issued or granted for AQS1301, following the U.S., Russia, Mexico, Japan, China, Canada, and Australia.

Moreover, Aequus Pharmaceuticals continues to increase revenues from its Canadian commercial arm via the on-going promotion of Vistitan™ and Tacrolimus IR. Vistitan™ (bimatoprost 0.03%) is a treatment for the lessening of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

Tacrolimus IR is the first to market, and currently the only available generic version of tacrolimus immediate release in Canada. This is a product used for the treatment and prevention of acute rejection following organ transplantation.

Aequus Pharmaceuticals, Inc. (AQSZF), closed Monday's trading session at $0.2343, up 8.52%, on 10,000 volume with 8 trades. The average volume for the last 60 days is 74,291 and the stock's 52-week low/high is $0.115/$0.356.


American Lithium Corp. (LIACF)

MarketWatch and Barchart reported on American Lithium Corp. (LIACF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

American Lithium Corp. engages in the acquisition, exploration, and development of lithium deposits within mining-friendly jurisdictions throughout the Americas. The Company’s Fish Lake Valley lithium brine properties are roughly 38 kilometers from Albemarle's Silver Peak (the largest lithium producer in the U.S). American Lithium is headquartered in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.

American Lithium holds options to acquire Nevada lithium brine claims totaling 22,332 acres (9,038 hectares). This includes 18,552 contiguous acres (7,508 hectares) in Fish Lake Valley, Esmeralda County; and the 2,240-acre (907-hectare) San Emidio project in Washoe County.

Fish Lake Valley is one of the most promising and largely undeveloped lithium brine basins in Nevada. Its geological and geophysical characteristics are alike to the Clayton Valley basin situated to the southeast.

The Q2-2016 acquisition of the Fish Lake Valley land package includes the North and South Bowl Playas. The acquisition encompasses all key structures of the North and South Bowl Playas that contain the lithium brines, and where gravity data shows distinct gravity lows.

The San Emidio Project is 60 miles (100 km) northeast of Reno - home to Tesla's Gigafactory. Lithium concentrations in brines at San Emidio are reasonably expected to increase at depth. This is also the case at Clayton Valley.

A gravity geophysical survey indicates an earlier discovered near surface lithium brine anomaly on the west side of basinal low. Anomalous lithium values were detected during brine sampling. The highest value was 80 mg/L.

Last month, American Lithium reported that following a strategic review of its existing property portfolio in Nevada, it has elected to expand its existing holdings in Fish Lake Valley, Esmeralda County. The Company is already the dominant land holder in the Valley, with 18,552 contiguous acres under management.

American Lithium has now entered into an agreement to acquire an additional 3,575 acre parcel in the Valley, consisting of 167 contiguous claims called the Gap-Lode Project. This Project overlies 2,480 acres of public land. The Gap-Lode Project is neighbouring an existing 1,094 acre claim block.

The Project is prospective for lithium deposits of numerous kinds. Principal among these kinds is lithium claystone, with a number of sub-types recognized in initial due diligence.

American Lithium Corp. (LIACF), closed Monday's trading session at $0.619, up 1.64%, on 5,300 volume with 5 trades. The average volume for the last 60 days is 5,953 and the stock's 52-week low/high is $0.263/$1.106.


HealthLynked Corp. (HLYK)

OTC Markets and InvestorsHub reported on HealthLynked Corp. (HLYK), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

HealthLynked Corp. concentrates on improving healthcare services for patients and physicians. The Company’s technology reduces wait times with online scheduling of appointments and real-time appointments by local providers. Additionally, its technology provides easy access to an individual’s and their family’s updated medical records. HealthLynked is based in Naples, Florida. The Company began trading on the OTC Markets Group’s OTCQB in May of 2017.

HealthLynked focuses on improving healthcare through connecting patients with their healthcare providers. The HealthLynked Network centers on the efficient, secure exchange of medical information between patients and their healthcare providers.

The cloud-based HealthLynked Network lets patient's medical records move with them. This is so one’s medical records are not fragmented in numerous healthcare systems and/or EHR (Electronic Health Record) systems.

Healthcare experts can easily be in touch with patients. They can provide their advice in case of emergencies by way of the Telemedicine Portal. The HealthLynked Healthcare Summary allows patients to maintain a complete medical profile in coordination with physicians. All information is systematically categorized. Therefore, physicians have a complete overview of patient health without them having to fill unnecessary paperwork.

HealthLynked profile information safeguards that doctors don't prescribe potentially harmful medications in case a patient forgets to mention one or more current medications while talking to their doctor. In addition, the HealthLynked Healthcare Summary page permits patients to keep their medical records updated. This helps physicians to be more productive and provide valid medical care.

Recently, HealthLynked announced the creation of its Health Advisory Board (HAB). The HAB consists of Healthcare providers from a spectrum of medical specialties who provide feedback on the HealthLynked software, online network, marketing services and medical record exchange. The initial board comprises four innovative thought leaders in their specialties ranging from Urology to Pediatrics.

Last week, HealthLynked reported its results for Q4 and full year 2017. Revenues for Q4 2017 were $629,940. This represents an increase of 46 percent over the same period in 2016. For the full year 2017, Revenue was $2,103,579. This represents an increase of 8 percent over full year 2016 revenue of $1,945,664.

The Company’s health services subsidiary achieved Operating Income of $19,321 in Q4 2017, versus an Operating Loss of $105,108 in Q4 2016. This represents an improvement of $124,429. The 2017 Operating Loss at the health services subsidiary was $168,343, versus an Operating Loss of $433,060 in 2016. This represents an improvement of $264,717.

HealthLynked Corp. (HLYK), closed Monday's trading session at $0.095, up 16.71%, on 82,250 volume with 4 trades. The average volume for the last 60 days is 21,977 and the stock's 52-week low/high is $0.03/$0.90.


Mobivity Holdings Corp. (MFON)

Zacks and Investors Hub reported earlier on Mobivity Holdings Corp. (MFON), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Formed in 2007, Mobivity Holdings Corp. provides a platform for intelligent and personalized marketing in the real world. The Company takes advantage of detailed purchase data and communications platforms to improve business results through understanding, predicting, and influencing consumer behavior. Mobivity helps restaurant and retail brands grow their business through increasing customer frequency, engagement, as well as spend. Mobivity Holdings lists on the OTC Markets’ OTCQB. The Company is based in Arizona.

Mobivity Holdings drives better actions and informs decisions through connecting Point of Sale (POS) outcomes to the events and influences that caused them. Its platform comprises software for phones, tablets PCs, and POS systems. These enable resellers, brands, and enterprises to market their products and services to consumers via text messages sent directly to consumers by way of mobile phones, mobile smartphone applications, and printed receipt content.

The Company has its SmartSuite Platform. With SmartSuite, restaurant and retail enterprises can unlock the power of customer, employee, and transaction data to constantly adapt, optimize, and also provide the most personalized, relevant, and targeted customer experiences.

Mobivity Holdings operates in more than 40,000 locations. It handles 125M+ monthly SmartTransactions. Along with the SmartSuite Platform, Mobivity’s products include SmartMessenger, SmartReceipt®, SmartScan, SmartAnalytics, SmartAds, Nutricate, Refer-a-Friend+, and Loyalty+.

The Company’s SmartSuite is used to boost participation in one-to-one marketing and customer engagement via mobile first interactions. Mobivity’s SmartSMS and SmartReceipt products assist brands in aggressively interacting with a following of consumers who can help a client increase top-line sales via suggestive selling. Mobivity’s clients include SUBWAY®, SONIC®, Chick-fil-A, and Baskin-Robbins.

Last month, Mobivity Holdings and Smashburger announced the initial results of its partnership to utilize Mobivity’s SmartReceipt technology to drive increased revenue, customer engagement, and customer satisfaction at Smashburger restaurants. Smashburger realized more than $200,000 in attributable revenue within the first 45 days of the program being launched at 190 of its corporate-owned locations.

Smashburger is a foremost fast casual better burger restaurant. It has a reputation for its fresh never frozen, beef burgers, which are smashed on the grill to sear in the juices and seal in the flavor.

Mobivity Holdings’ SmartReceipt enables Smashburger to reformat its receipts from plain transaction record into a vibrant communications medium with customized offers for each consumer based on what they bought. Transaction details for every receipt are compiled in the cloud. Here, the data is applied to machine learning and other cognitive technologies to instruct future offers and predict results.

Additionally, in November, Mobivity announced financial results for Q3 ended September 30, 2017. Year-to-date revenues for the first nine months of 2017 increased 5 percent to $6.4 million versus $6.1 million for the same period in 2016. In addition, deferred revenue grew 1,200 percent to $2.1 million at September 30, 2017 versus $160,000 at September 30, 2016.

Total minimum contract values in 2017 grew to $19.3 million. This represents an increase of over 260 percent over $5.3 million in minimum contract values at the same time in 2016. Average contract term rose 150 percent year over year, from 1 year to nearly 2.5 years.

Mobivity Holdings Corp. (MFON), closed Monday's trading session at $1.10, up 1.85, on 7,643 volume with 9 trades. The average volume for the last 60 days is 14,378 and the stock's 52-week low/high is $0.55/$1.80.


FieldPoint Petroleum Corp. (FPPP)

OTC Markets, Equity Clock, Stock Twits, InvestorsHub, TMX Money, MarketWatch, and The Street reported on FieldPoint Petroleum Corp. (FPPP), and today we chose to report on the Company, here at the QualityStocks Daily Newsletter.

FieldPoint Petroleum Corp. engages in the acquisition, development, and operation of oil and natural gas properties in the United States. The OTCQB-listed Company engages in oil and natural gas exploration, production and acquisition, chiefly in Louisiana, New Mexico, Oklahoma, Texas, and Wyoming. Established in 1989, the Company is based in Austin, Texas.

FieldPoint Petroleum’s business strategy centers on expanding its reserve base. This is while growing production and cash flow through the acquisition of leasehold interests and producing oil and gas wells. Currently, FieldPoint has varying ownership interests in 480 gross producing wells (96 net) in the aforementioned States.

More recently, the Company has chosen to focus on promising areas for oil & gas exploration. These include the Lusk Field in Lea County, New Mexico, and FieldPoint’s Ranger Project in the Taylor Serbin Field near Giddings, Texas. In projects like these, FieldPoint Petroleum partners with enterprises that complement internal expertise in assessing opportunities and in making investment decisions.

Regarding producing oil & gas properties, FieldPoint operates 19 wells. Independent contractors operate the other wells per standard industry contracts.

Concerning operated wells, the Company’s portfolio includes mainly low-touch, “pumper and electricity-only” wells in the Devonian, Ellenberger, and Morrow areas of West Texas and New Mexico.

Higher maintenance fields are closer to home. This includes the Taylor Serbin field close to Giddings, Texas. The majority of the Company’s production comes from its East Lusk and Serbin Fields.

FieldPoint Petroleum is active in Lea County, Chaves County, and Eddy County in New Mexico. In Wyoming, the Company is active in Converse County and Campbell County.

In Texas, FieldPoint Petroleum is active in Andrews County, Midland County, and Lee & Bastrop Counties. In Oklahoma, it is active in Grady County and Pontotoc County. In Louisiana, FieldPoint is active in Caddo Parrish.

Last week, FieldPoint Petroleum announced financial results for the Fiscal Year (FY) ended December 31, 2017. 2017 financial highlights versus 2016 include Revenues increasing to $3,036,132 from $2,800,921. Net Income rose to $2,666,253 from ($2,473,147). Furthermore, Income per Share increased, basic to $0.25 from ($0.27) and fully diluted to $0.25 from (0.27).

Mr. Phillip Roberson, FieldPoint Petroleum President and Chief Financial Officer (CFO), said, "The past three years have been challenging for the oil and gas industry, but 2017 brought signs of recovery. Our revenues increased toward year end, but more importantly, market improvement made it possible for us to divest some non-producing assets and pay down a significant portion of our debt.”.

FieldPoint Petroleum Corp. (FPPP), closed Monday's trading session at $0.164, down 4.09%, on 85,000 volume with 12 trades. The average volume for the last 60 days is 9,889 and the stock's 52-week low/high is $0.10/$0.20.


Metso Corporation (MXCYY)

Stockhouse,, Zacks, Stockwatch, StreetInsider, OTC Markets, The Street, TipRanks, WalletInvestor, YCharts, TradingView, Marketbeat, and Amigobulls reported on Metso Corporation (MXCYY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Metso Corporation is a world-leading industrial company. It offers equipment and services for the sustainable processing and flow of natural resources in the mining, aggregates, recycling and process industries. The Company employs more than12,000 people in over 50 countries. Metso has its corporate office in Helsinki, Finland.

The Company’s offering includes products, systems, projects and services business. Large-scale project deliveries are normal for the mining industry, whereas Metso’s deliveries to the aggregates and oil and gas industries primarily comprise individual equipment deliveries and smaller product packages.

Metso’s products range from mining and aggregates processing equipment and systems to industrial valves and controls. It supports its customers through an extensive range of services and an international network of greater than 80 service centers and approximately 6,000 services professionals.

The Company has a comprehensive offering. For example, concerning Pumps, it has a wide range of slurry pumps, hoses and valves for mines, mineral processing plants, quarries, and other slurry pump customers. Regarding Aggregates Equipment, Metso has crushing and screening products and related systems for the aggregates industry.

Pertaining to Recycling, the Company has equipment and services for mechanical treatment of metal scrap and solid waste to automotive industry, scrap yards, steel mills, waste handlers, plant builders and the cement industry. Concerning Valves, it has valves and related services for diverse process industries. For example, oil and gas in mid and downstream, petrochemical and chemical, industrial gas, pulp and paper, power and other process industries.

Last month, Metso announced that it signed a significant service agreement. This includes refurbishment services for screening equipment used in mining applications, related spare parts and support. The new agreement is the Company’s largest service contract of this kind in the Brazilian market. This agreement covers a period of three years.

Last week, Metso announced that it signed an agreement to acquire the valve automation division of the India-based valve technology company Rotex Manufacturers and Engineers Pvt. Ltd (RMEPL). The company has a market-leading position in India in the actuator business. In addition, it has an advanced offering of switches, process valves, as well as valve automation products and solutions.

This acquisition will complement Metso's actuation and valve automation offering. The acquisition will enable a complete range of actuators for all major valve markets and a more extensive offering of limit switches for mid-market applications.

Today, Metso announced it has agreed to acquire the mobile crushing and screening plant provider P.J. Jonsson och Söner (headquartered in Sweden). With this acquisition, Metso aims to strengthen the scope and availability of its product and service offering for the aggregates industry in the Nordics. The expectation is that this acquisition will close in Q3 2018. P.J. Jonsson och Söner AB’s specialty is the supply of mobile crushing and screening plants to a broad range of customers throughout Sweden.

Metso Corporation (MXCYY), closed Monday's trading session at $7.58, even for the day, on 160 volume with 2 trades. The average volume for the last 60 days is 1,444 and the stock's 52-week low/high is $7.35/$9.36.


NEXT Group Holdings, Inc. (NXGH)

RedChip, BUYINS.NET, Penny Invest, StockEgg, and OTC Picks reported on NEXT Group Holdings, Inc. (NXGH), and we also report on the Company, here at the QualityStocks Daily Newsletter.

NEXT Group Holdings, Inc., through its operating subsidiaries, engages in utilizing proprietary technology and certain licensed technology to provide innovative mobile banking, mobility, and telecommunications solutions to underserved, unbanked, and emerging markets. NEXT Group Holdings owns 94 percent of the issued and outstanding shares of NEXTCALA, which is one of its four operating subsidiaries. NEXT Group Holdings is based in Miami, Florida and lists on the OTCQB

NEXT Group Holdings maintains a technology portfolio encompassing several verticals. The Companies subsidiaries are NEXT|CALA, a general purpose reloadable Visa Card; NXT|GN, a provider of a multipoint HD video platform; and NEXT|MOBILE360, a provider of mobile voice, text, and data services.

NEXT|CALA is its flagship product. NEXTCALA powers its mobile banking solution and reward program(s). The card is a safe and cost-effective substitute to carrying cash. NEXTCALA cards are acceptable wherever Visa debit cards are accepted. NEXTCALA cards can be used for all transactions.

The NXT|GN business unit, in cooperation with Cisco Systems, developed in 2012 a unique product named AVYDA powered by Telarix. This is an HD telepresence platform. It enables millions of people to connect using their mobile phones, tablets, and PCs into celebrities, talents, and healthcare and education applications on Android and iOS operating systems. AVYDA permits HD video conferences to connect point-to-multipoint.

Next Group Holdings has completed the acquisition of Tel3. Tel3 is a marketing group. With the agreement, the Company acquired the telecom marketing brand "Tel3" together with the assets and client database of Tel3.

Recently, Next Group Holdings announced it completed a significant milestone for the acquisition of international telecommunication company, Limecom, Inc. The execution of this Definitive Agreement was on September 19, 2017.

Upon completion of the acquisition, Limecom will become a wholly-owned subsidiary of NEXT Group Holdings, with projected revenues of more than $125 million for 2017, and EBITA (Earnings before Interest, Taxes and Amortization) projected at $2.5 million.

Last week, Next Group Holdings announced that on December 6, 2017, it completed its acquisition of 51 percent of SDI NEXT Distribution LLC. This was announced on August 24, 2017 as a Letter of Intent (LOI) with Fisk Holdings, LLC.

As Managing Member of the newly created LLC, Next Group Holdings will contribute $500,000, to be paid per an agreed-upon schedule over a twelve-month period commencing this month.  The completed acquisition comprises an established distribution business for third-party gift cards, mobile top up, financial services and content that currently includes over 30,000 U.S. retail locations.

Additionally, NEXT Group Holdings’ 51 percent stake in SDI NEXT provides distribution for the Company's recently announced CUENTAS and MIO virtual mobile banking solutions targeted at unbanked, underbanked, and financially underserved consumers.

NEXT Group Holdings, Inc. (NXGH), closed Monday's trading session at $0.0266, up 6.40%, on 16,202 volume with 1 trade. The average volume for the last 60 days is 340,029 and the stock's 52-week low/high is $0.018/$0.1449.


Blox, Inc. (BLXX)

SmallCapVoice, OTC Markets Group, and PennyStocks24 reported previously on Blox, Inc. (BLXX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Blox, Inc.’s vision is to pioneer the development of mining projects through applying green innovation to traditional mining methods and combining renewable energy and technology into the process. The Company’s plan is to become a global leader in the production of “green minerals”. An important component of Blox’s mandate is to implement clean energy into the mining process. This is to effectively “green” the mining process and minimize its environmental impact by way of lower hydrocarbon emissions. Blox Minerals is a wholly-owned subsidiary of Blox, Inc. OTCQB-listed, Blox has its corporate office in Vancouver, British Columbia.

The Company’s plan is to build a portfolio of gold and other minerals and produce them in a socially and environmentally friendly manner. Blox defines “green minerals” as minerals produced utilizing technologies, best practices, and mine processes implemented to lessen the environmental impacts associated with the extraction and processing of metals and minerals.

Box’s plan is to use renewable energy and technology in the production of green minerals with the aim of turning expensive costs into profits through utilizing renewable energy plants to power its varied projects.

Concerning technology, the basis of this division of Blox is rooted in the acquisition of the rights to proprietary Enterprise Resource Planning (ERP) software named “Abacus”. As Blox grows it will be able to manage its different operating and development projects with its own software system.

The Company’s key concession holdings are in Ghana and Guinea, West Africa. Its projects include Pramkese, Osenase, Asamankese, and Mansounia.

The Mansounia Exploration Licence is centered on Latitude 10º 23’ N and Longitude 9º 47’ W in the Kouroussa Prefecture, Kankan Region, in Guinea, West Africa. It covers a surface area of 145 square kms. At Mansounia, significantly fresh rock mineralization has been intersected and as of July 2016, remains unexplored. Mansounia is a priority development asset for Blox.

This past January, Blox provided an exploration update from its Mansounia Gold Project (MGP) in Guinea, West Africa. Sampling of oxidized outcrops at South-Central Mansounia at the Mansounia Gold Project returned significant results. These include Man002 - 0.98g/t in weathered breccia; and Man003 - 3.04g/t in weathered granitoid.

Results also include Man007 - 0.49g/t in intensely weathered breccia; and Man012 - 1.03g/t in weathered brecciated granitoid with iron-oxide rich quartz veins. Plans are underway to undertake auger drilling to the south of the presently drilled Mansounia resource, over the area where the above outcrop samples were taken. Reverse circulation (RC) and Aircore drilling is planned, based on the results of the auger geochemical sampling program.

Last week, Blox announced that it entered into a Strategic Alliance Agreement with Ashanti Sankofa Inc.  With the terms of the Strategic Alliance Agreement both parties agreed to grant to the other party a right of first refusal to enter into a joint venture (JV) on any of their respective properties and/or projects and that any future acquisition of natural resource properties that may be acquired by either party that contains, but is not limited to, gold, precious metals, technology metals or diamonds (Natural Resource Properties), the acquiring party will grant to the other party a right of first refusal to participate in a JV on such Natural Resource Property that shall be at the sole discretion of the acquiring party.

Blox, Inc. (BLXX), closed Monday's trading session at $0.24, even for the day. The average volume for the last 60 days is 2,836 and the stock's 52-week low/high is $0.0279/$0.35.


Sun Pacific Holding Corp. (SNPW)

Marketwired, Zacks, and reported on Sun Pacific Holding Corp. (SNPW), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Sun Pacific Holding Corp., through its subsidiaries, provides solar bus stops, solar trashcans and “street kiosks” using its innovative advertising offerings, which provide State and local municipalities with costs efficient solutions. The Company’s subsidiaries include Sun Pacific Power Corp, Street Smart Outdoor Corp., and Sun Pacific Security Corp. Sun Pacific Holding is based in Manalapan, New Jersey. The Company lists on the OTC Markets Group’s OTCQB.

A green energy company, Sun Pacific Holding specializes in solar and waste to energy technologies. Subsidiary Sun Pacific Power builds next generation solar panels and lighting products made primarily in the United States. Sun Pacific Power has eight global manufacturing and assembly locations. This includes five in the U.S.

Sun Pacific Holding’s subsidiary, Sun Pacific Security, will offer customers the latest in security automation systems. This subsidiary enables one to view secure, live and recorded video of their property at any time on their computer, smartphone or tablet. Sun Pacific Security has not started operations in the security sector; it is reviewing plans to provide customers the latest in security automation systems.

Company subsidiary, Sun Pacific Power, acquired final design of its Smart Solar Bus Shelter in 2016. It began deploying it in Sayreville and Howell, New Jersey. The Smart Solar Bus Shelter provides LED lighting for increased visibility and security as well as other technological additions not previously available. Sun Pacific Power provides solar powered bus shelters, solar powered LED trash bins, solar products, as well as lighting products.

Street Smart Outdoor is Sun Pacific’s street furniture outdoor advertising subsidiary. It is presently maintaining advertising space on greater than 1,000 bus shelter faces, bus benches, smart solar digital shelters and solar trash bins.

This past January, Sun Pacific Holding announced its move to integrate blockchain technology into its renewable energy business model and strategy designed to improve grid management efficiency for solar and wind farms. This news comes after the Company announced that it signed a Letter of Intent (LOI) to purchase 60 acres of land to build a solar and wind farm, where electricity generation will be optimized via a combination of both energy sources.

In addition, Sun Pacific Holding announced its plans to take the project one step closer to the future through employing blockchain technology to monitor the new grid, load balance, and increase the life of electrical equipment.

Sun Pacific Holding is building a “Next Generation” Green Energy Company through offering competitively priced solar panel and lighting products. Another subsidiary of the Company is National Mechanical Group.

Sun Pacific Holding has key Contracts. It signed contracts with Star Metro Transportation Authority in Tallahassee, Florida, and the State of Rhode Island Transportation Authority.

Regarding Renewable Energy, it has contracted to build the first plant in New England capable of treating medical waste that also creates clean energy.

Sun Pacific Holding Corp. (SNPW), closed Monday's trading session at $0.16955, up 15.84%, on 268,146 volume with 106 trades. The average volume for the last 60 days is 51,148 and the stock's 52-week low/high is $0.045/$0.82.


The QualityStocks Company Corner

Sharing Services, Inc. (SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Sharing Services, Inc. (OTC: SHRV), headquartered in Plano, Texas, is a diversified holding company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits.

Sharing Services, Inc. (SHRV) headquartered in Plano, Texas, is a diversified holding company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth, and sending as many successful company “families” as possible on vacation.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders –  Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed Today's trading session at $0.3499, up 16.25%, on 24,161 volume with 9 trades. The average volume for the last 60 days is 47,599 and the stock's 52-week low/high is $0.125/$1.15.

Recent News


Petrogress, Inc. (PGAS)

The QualityStocks Daily Newsletter would like to spotlight Petrogress, Inc. (PGAS).

Petrogress (OTC: PGAS), a diversified marine transport and offshore services company, is working toward expanding its operations in West Africa to capitalize on the region’s mounting potential. To view the full article, visit:

Petrogress, Inc. (OTCQB: PGAS), founded in 2009, owns and operates a fleet of tankers from its base in the historic Port of Piraeus, Greece, through a series of Marshall Islands subsidiaries. The company is an international merchant of petroleum products which includes reliably marketing and trading crude oil, distillates, and refined products off the coast of West Africa. The company also operates service and shipping facilities at the Port of Limassol in Cyprus and the Port of Tema, Greater Accra, in Ghana. It is actively seeking expansion opportunities, including in operating and developing natural gas production and transmission facilities along with LNG processing in the U.S., refinery operations in north and west Africa, and the transport and sales of LNG in Europe.

Petrogress has created a diversified revenue stream, giving it a significant advantage over similar companies working in the oil and gas shipping arena. A case in point is the recent formation of “PG Cypyard & Offshore Service Terminal Ltd. (“Cypyard”), through the company’s wholly owned subsidiary, Petrogress Int’l, LLC. Cypyard is concluding negotiations for an operations and management agreement covering ports in Hellenic Cyprus, including the Port of Limassol, directly with the Cyprus Ports Authority. Current plans include a long-term lease with renewal options covering all in-place port facilities, including floating dock and dry dock areas, with cranes and scaffolding, construction and repair workshops and storage, and complete on-site administrative and office space.

“I think the opportunities there are great, and dealing directly with partners in government has numerous benefits,” said Christos P. Traios, president of Petrogress Inc. in a news release announcing the venture. The recent appointment of two industry experts to the Petrogress Advisory Board is expected to help the company capitalize on future growth opportunities while simultaneously developing a comprehensive U.S. and international lobbying and government outreach program to facilitate business plans in the U.S., European Union and Africa.

Additional Petrogress Inc. subsidiaries are:

  • Petrogress Co. Ltd., an international merchant of petroleum products that combines regional market knowledge with over 20 years of excellent shipping experience.
  • Petronave Carriers LLC, which manages an in-house fleet of crude oil carriers and trades them in West Africa, a country known as a difficult area for navigation and trade.
  • Petrogress Oil & Gas Energy Inc., which has expansion plans through a supply of liquified natural gas located in the oil fields of Texas with an eye toward exporting LNG to Mediterranean markets.

Petrogress continues to “adjust its sails” in order to meet new challenges. Opportunities include upstream oil resources and exploration, the addition of more product fleet carriers, downstream movement of petroleum products from refineries to finished sales, and sea transportation of liquified natural gas. A closely followed economist, Jim O’Neill, states that oil prices could spike more than 25% in the next year. O’Neill, now an economics professor at the University of Manchester, says the market is finally waking up to the fact that global economic growth is gaining momentum and likely expanding at 4 percent or higher. That means there will be more demand for oil, the article states, which translates into brighter days ahead for companies like Petrogress.

Petrogress, Inc. (PGAS), closed Today's trading session at $0.02, up 4.71%, on 128,151 volume with 8 trades. The average volume for the last 60 days is 198,918 and the stock's 52-week low/high is $0.0166/$0.072.

Recent News


Hiku Brands Co. Ltd. (DJACF)

The QualityStocks Daily Newsletter would like to spotlight Hiku Brands Co. Ltd. (DJACF).

Hiku Brands Company Ltd. (CSE: HIKU), Canada's first vertically-integrated cannabis brand house, is pleased to announce its wholly owned subsidiary DOJA Cannabis Ltd. ("DOJA"), a licensed cannabis producer under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR"), received an amendment to its license from Health Canada to include the sale of dried cannabis, cannabis plants and seeds, effective April 6, 2018.

Headquartered in British Columbia’s picturesque Okanagan Valley, Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) iis a premium cannabis lifestyle brand growing high-quality handcrafted cannabis flower. Hiku’s wholly owned subsidiary is a licensed producer of cannabis under the ACMPR that has requested its Pre-Sales License Inspection, the last step prior to receiving a license to sell cannabis under the ACMPR. Hiku’s Dominion Facility is a state-of-the-art ACMPR licensed production facility capable of producing approximately 660 kg year of dried cannabis flower. Hiku’s second facility, a 22,580 sq ft warehouse, “the FUTURE LAB”, is targeting its Phase 1 completion by Q2 2018 and once the facility is fully built-out utilizing an industry leading multi-tier system powered by LED lighting provided by Fluence BioEngineering, Hiku’s annual production capacity is expected to be in excess of 5,000 kgs. Hiku was founded by the proven entrepreneurial team that started SAXX Underwear®.

On December 21, 2017, Hiku and TS Brandco Holdings Inc. (“Tokyo Smoke”) announced that they have entered into a binding Letter of Intent (“LOI”) to merger the two companies and create a uniquely positioned cannabis company combining a best-in-class craft cannabis producer with an award-winning lifestyle brand and retail-focused cannabis company. It is anticipated that the combined company resulting from the merger will use the name “Hiku Brands Company Ltd.” (“Hiku”) to refer to the brand house containing premium cannabis brands DOJA, Tokyo Smoke, and Van der Pop.

Hiku recently closed on a $10 million strategic equity investment from Aphria Inc. (“Aphria”) (TSX:APH and US OTC: APHQF) to expand their product offering ahead of the recreational market.

Upon completion of the merger, Hiku will have a robust cash position of approximately $31 million, which it plans to invest in expanding its cannabis production capacity, growing its retail footprint, and adding select brands to its portfolio through highly strategic and complementary acquisitions.

About Tokyo Smoke
Founded in 2015 by Alan and Lorne Gertner, Tokyo Smoke is an award-winning cannabis lifestyle brand that brings sophistication and design to the fast-growing industry. With immersive experiences and design-first, non-dispensary retail spaces selling coffee, cannabis accessories and design products, the brand has six locations in Canada, with plans to expand nationwide. Recently named “Brand of the Year” at the Canadian Cannabis Awards, Tokyo Smoke has showcased excellence in brand storytelling, and has developed an international reputation as the go-to destination for engaging content offerings within the industry. With the acquisition of fellow designer cannabis brand Van der Pop, and by partnering with Aphria Inc. (TSX: APH and US OTC: APHQF) and WeedMD (TSXV: WMD), Tokyo Smoke continues to be the leading Canadian brand in the cannabis space.

About Hiku
Hiku is focused on handcrafted cannabis production, immersive retail experiences, and building a portfolio of iconic, engaging cannabis lifestyle brands. Hiku is differentiated as the only Canadian craft cannabis producer with a significant national retail footprint and a growing brand house including premium cannabis lifestyle brands DOJA, Tokyo Smoke, and Van der Pop.

Hiku’s wholly owned subsidiary, DOJA Cannabis Ltd., is a federally licensed producer pursuant to the ACMPR, owning two production facilities in the heart of British Columbia’s Okanagan Valley. The company operates a network of retail stores selling coffee, clothing and curated accessories, across British Columbia, Alberta and Ontario.

Hiku Brands Co. Ltd. (DJACF), closed Today's trading session at $1.31, up 0.08%, on 157,767 volume with 252 trades. The average volume for the last 60 days is 134,165 and the stock's 52-week low/high is $0.20/$3.8799.

Recent News


Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy (TSX.V: PQE) (OTCQX: PQEFF), a company focused on the development and implementation of proprietary technologies for the energy industry, continues to strategically invest in revolutionary endeavors. To view the full article, visit:

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed Today's trading session at $0.8709, up 0.10%, on 39,583 volume with 64 trades. The average volume for the last 60 days is 140,252 and the stock's 52-week low/high is $0.015/$1.8892.

Recent News


PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced a non-brokered private placement of up to 16 million units at the price of $0.25 per unit for total gross proceeds of up to CAD$4,000,000. To view the full press release, visit:

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed Today's trading session at $0.2262, up 0.58%, on 5,215 volume with 4 trades. The average volume for the last 60 days is 25,995 and the stock's 52-week low/high is $0.01/$0.80.

Recent News


Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO).

Zenosense, Inc. (OTC: ZENO) is a healthcare technology developer that participates in transformational, disruptive medical diagnostic projects; particularly handheld devices used at the Point of Care which are displacing slow and expensive laboratory tests.

Zenosense, Inc. (ZENO) (the “Company”) is a healthcare technology developer that participates in transformational, disruptive medical diagnostic projects; particularly handheld devices used at the Point of Care which are displacing slow and expensive laboratory tests.

Zenosense is primarily focused on the development and commercialization of MIDS Cardiac™ through the Company’s joint venture ownership in MIDS Medical Limited (“MML”). MIDS Cardiac is in development as a cost-effective, handheld Point of Care (“POC”) diagnostic device and disposable test strip for the early, rapid detection of suspected acute myocardial infarction (“AMI”, or “heart attack”).

Identification of very low levels of cardiac markers can significantly accelerate critical triage, diagnosis, treatment and disposition of patients reporting chest pain. Cardiac troponin is well documented as the preferred biomarker for diagnosis of AMI, with evidence continuing to demonstrate that high sensitivity troponin is the most powerful prognostic biomarker for the assessment of cardiovascular risk in the general population. However, highly sensitive troponin assays are currently available only on state of the art, central laboratory analyzers. These analyzers are extremely expensive, not generally available at the POC and slow to turnaround results (typically 60 minutes) when time is critical.

True, high-sensitivity devices are not available in smaller handheld devices at the POC, where they are most needed. This is because the optical detection systems generally used in central laboratory analyzers cannot be effectively miniaturized.

MIDS Cardiac uses the patented MIDS technology platform, exclusively available to MML. Instead of using conventional optical detection, MIDS can detect and quantify assay beads nano-magnetically. This means it can be incorporated in a small device expected to achieve highly sensitive detection levels, which can support true high sensitivity cardiac biomarker tests in emergency settings, at the POC.

Harnessing world-class expertise, the MML laboratory is located at the prestigious Sci-Tech Daresbury campus in the U.K., internationally recognized for leading-edge, scientific research and commercial development. MML has the sole rights to the MIDS technology platform, which is protected by patent applications already granted in China and the USA, and applications now in the national phase in all other key geographic areas.

MIDS Cardiac aims to provide a single troponin I or T test within 3 minutes and three panel assay (additional cardiac biomarkers) on a disposable test strip within 8 minutes, using a hand-held device costing a fraction of the price of laboratory analyzers.

MIDS Cardiac should only require a pin prick of blood for a single assay test carried out on an easy-to-use, disposable microfluidic test strip. MIDS Cardiac is being designed to be operated quickly by minimally trained personnel, producing a simple to interpret result in emergency settings, even in the back of an ambulance.

Initial testing of the electronic and microfluidic components of the MIDS Cardiac “Hybrid Strip” system was completed in November 2017. The Hybrid Strip system used for development testing aims to replicate as closely as possible a fully integrated Lab on Chip MIDS test strip set-up. Development testing was conducted on both the assembled hybrid unit and its electronic and microfluidic components separately, focusing mainly on the electronics of the magnetic sensing system.

Testing revealed that a variety of brands and sizes of commercially available assay beads could be magnetically detected in very low quantities, including samples of beads that were previously undetectable. In several instances, the current “limit of detection” appeared to already be at or near to the range advised by MML’s assay consultants as suitable for a high sensitivity troponin assay.

Dr. Nasser Djennati, MML’s Managing Director and Chief Scientific Officer, said; “These results come in at the very high end of detection expectations, even at this Hybrid Strip stage. As we move forward into true Lab on Chip construction, I expect detection levels to improve further still.”

Cardiovascular disease is the leading cause of death in the western world, accounting for more than 17 million deaths in Europe and the United States alone. Nearly 20 million patients each year visit an emergency room with reports of chest pain, with hundreds of millions spent on unnecessary admissions to the hospital. Zenosense Inc. is confident MIDS Cardiac will deliver unparalleled levels of accuracy, speed, reliability, ease of use and cost savings, making it the future device of choice for hospitals, emergency rooms, medical practitioners, paramedics and in low-resource settings.

The MIDS technology is also seen as having a far wider application, with the platform being capable of performing Point of Care immunoassay tests for a vast array of common healthcare concerns, a market projected to be worth $23.7 billion per year worldwide by 2019. The medical testing market as a whole is projected to be worth $53.34 billion by 2021. Zenosense believes the MIDS technology could be the most significant advance in diagnostic testing services in decades.

Zenosense, Inc. (ZENO), closed Today's trading session at $0.3601, off by 9.95%, on 72,609 volume with 59 trades. The average volume for the last 60 days is 168,974 and the stock's 52-week low/high is $0.2021/$4.00.

Recent News


PotNetwork Holding Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holding Inc. (POTN).

PotNetwork Holding, Inc. (OTC Pink:POTN) On Monday April 9th, 2018 PotNetwork Holding, Inc.’s wholly owned subsidiary, Diamond CBD, Inc. announced the brand’s participation at the 2018 Telecom Review Summit held in Beirut, Lebanon.

PotNetwork Holding, Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company’s First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holding.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies – Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies – Chill gummies are more robust than its counterpart, the “Relax” gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold – CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD – Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies – Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that’s looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet – CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf – Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD – Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot – CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it’s that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill – CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holding continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holding Inc. plans to expand its subsidiaries as well as make strategic acquisitions.

PotNetwork Holding Inc. (POTN), closed Today's trading session at $0.353, off by 5.11%, on 2,529,239 volume with 660 trades. The average volume for the last 60 days is 11,790,459 and the stock's 52-week low/high is $0.0006/$0.957.

Recent News


IEG Holdings Corp. (IEGH)

The QualityStocks Daily Newsletter would like to spotlight IEG Holdings Corp. (IEGH).

A leading fintech company and direct lender licensed in 20 states, Las Vegas-based IEG Holdings Corp. (OTCQB: IEGH) is offering a unique and approachable consumer lending model based on the concept of online unsecured loans with fast approval rates and affordable repayments. Also today, NetworkNewsWire released a report on the company detailing how IEGH was the subject of a ACF Equity Research report in January 2018, which projected that IEGH revenues will quadruple from 2017 estimates by 2020 ( To view the full article, visit:

IEG Holdings Corp. (OTCQB: IEGH) is a publicly traded, global leader in consumer finance providing small-sized online personal loans in the United States via a state-licensed operating subsidiary, Investment Evolution Corporation, under the consumer brand “Mr. Amazing Loans.” Based in Las Vegas, the company originates consumer loans in 20 states: Alabama, Arizona, California, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Missouri, Nevada, New Jersey, New Mexico, Ohio, Oregon, Pennsylvania, Texas, Utah, Virginia and Wisconsin via its online platform and distribution network. IEGH is a licensed direct lender with state licenses and/or certificates of authority to lend in each state and offers all loans within the prevailing statutory rates.

Mr. Amazing Loans is a leading FinTech company specializing in dedicated loan amounts of $5,000 to $10,000 offered directly to consumers through an easy-to-use website known for its professional interaction with applicants. All loans are originated, processed and serviced out of the company’s Las Vegas corporate offices, eliminating the need for physical locations in each state where IEGH is licensed to conduct business. The company’s loans are unsecured consumer loans that mature in five years at interest rates significantly less than those of payday lenders. Consumers are able to receive same-day processing and are assured of no hidden or additional fees, no prepayment penalty, with repayment and interest rates fixed at 29.9% or less Annual Percentage Rate (APR) for the life of the loan.

The Center for Responsible Lending states the typical payday loan has rates ranging from 391% to 521% APR on loans that typically range from $100 to $1,000. Conversely, Mr. Amazing Loans’s terms are designed with low fixed repayments to fit into consumer budgets with the added goal of helping clients reach a stronger financial position. Loan funds are deposited directly into an approved consumer’s checking account and may be approved the same day after necessary application documentation is received.

IEG Holdings has also incorporated Investment Evolution Crypto, LLC., a 100 percent owned subsidiary, and tasked the new company with exploring business opportunities in the cryptocurrency/blockchain industry. Specifically, the subsidiary company will explore the legalities and economic risks of entering into a joint venture with IEGH’s other 100 percent owned subsidiary company, Investment Evolution Corporation dba Mr. Amazing Loans. Among the questions to be answered during this development planning stage are whether Mr. Amazing Loans should accept repayment of customer loans in the form of leading crypto/blockchain currencies such as Bitcoin, provide the equivalent of USD $5,000 and $10,000 loans to consumers in cryptocurrencies, and potentially create and issue an Investment Evolution cryptocurrency.

Paul Mathieson, IEG Holdings’ chairman and Chief Executive Officer, has over 19 years of finance industry experience in lending, funds management, stock market research and investment banking. He has been a member of the board of directors at IEGH since 2012 and of its subsidiary since 2009. Mathieson founded IEG Holdings Limited in Sydney, Australia, launching the Amazing Loans business in that country in 2005 and then in the United States via IEGC in 2010. He was awarded Ernst & Young’s 2007 Australian Young Entrepreneur of the Year (Eastern Region). Mathieson is joined by Carla Cholewinski, who serves as chief operating officer with over 37 years of experience in the finance industry including banking, credit union management, regulatory oversight, debt securitization and underwriting.

IEG Holdings Corp. (IEGH), closed Today's trading session at $0.24, off by 7.69%, on 17,685 volume with 8 trades. The average volume for the last 60 days is 29,098 and the stock's 52-week low/high is $0.14/$4.19.

Recent News


Epazz, Inc. (EPAZ)

The QualityStocks Daily Newsletter would like to spotlight Epazz, Inc. (EPAZ).

Epazz (OTC: EPAZ), a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions, is preparing for the anticipated debut of its provisional patent-pending Cordtell smart contract technology. To view the full article, visit:

Epazz, Inc. (EPAZ) is a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. The company’s strategic expansion into the investment fintech software space can be seen in the recent acquisition of the android app CryptoFolio, which securely tracks and manages Bitcoin and Altcoin portfolios. Epazz, Inc., which acquired the software rights, source code and user base of CryptoFolio, plans to add additional cryptocurrencies and languages to the app, along with an iOS version to attract more users.

Epazz also offers ZenaPay Bitcoin wallet, which has been downloaded more than 10,000 times since its launch on the Play Store. A subsidiary of Epazz, ZenaPay is a financial technology company that offers a unique, secure and reliable Bitcoin payment app, allowing consumers to acquire Bitcoin at the point-of-sale. The consumer can then use this digital currency to make a purchase with ease. The CryptoFolio business model provides free features to attract users and then allows users to purchase additional features from $1.99 to $5.99 each. CryptoFolio is a great add-on app for ZenaPay, and future versions of CryptoFolio will include an option to download ZenaPay.

“We are starting 2018 with ZenaPay on both major mobile apps’ platforms,” said Shaun Passley, PhD, CEO and founder of Epazz. “We are in the processing of developing new blockchain technology which will introduce an additional source of revenue streams for our company.”

Epazz technology makes it easy to convert legacy systems into cloud business process software, for which the company then charges an annual subscription fee. Epazz has acquired 11 software companies that have converted or are in the process of converting their legacy software products to cloud software using Epazz technology. Epazz then markets the new cloud-based solutions to new and existing customers.

Epazz’s unique BoxesOS™ applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce. Epazz has also filed a provisional patent for its new blockchain smart legal contract technology that reduces fraud in business transactional contracts. The technology allows for a transactional contract to become a living contract that is tracked and traced; it also verifies that a section of terms within a contract are followed and that all parties of an agreement obey the terms of the contract.

“Blockchain-based technology is the future of the Internet,” Passley said. “Epazz will add blockchain technology to all of our products in the coming months using our blockchain cloud platform, BoxesOS. The company has been working with customers to understand the best uses of blockchain, and we are excited about filing the first of many blockchain patents, with many more to come.

Epazz, Inc. (EPAZ), closed Today's trading session at $0.0913, off by 8.24%, on 69,748 volume with 21 trades. The average volume for the last 60 days is 276,468 and the stock's 52-week low/high is $0.0045/$0.52.

Recent News


Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, recently announced that February marked the company’s highest-ever sales revenue month. To view the full article, visit:

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed Tuesday's trading session at $0.70, off by 9.09%, on 3,315 volume with 13 trades. The average volume for the last 60 days is 32,519 and the stock's 52-week low/high is $0.324/$1.75.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.